.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Reinhard Henschler

Engagements

21/09/2022

15:00 – 15:20 15 Min. 5 Min.
Vortrag
VS-6-2
Transfusion of thrombocytes according to guidelines and with extended antigen matching
15:20 – 15:30 6 Min. 4 Min.
Abstractvortrag
VS-6-3
Analysis of Platelet Product Utilization at a University Hospital Reveals Optimization Potential in Guideline Adherence
16. Rechtliche Grundlagen, Qualitätssicherung und regulatorische Aspekte, 9. Hämotherapie

22/09/2022

16:30 – 18:15
Postersession
Hämovigilanz | Immunhämatologie und immunologische Grundlagen II. | Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie |Pädiatrische Transfusionsmedizin
Foyer 1.2
16:30 – 16:35 3 Min. 2 Min.
Poster
PS-3-1
Systematic analysis of adverse transfusion reactions reveals both, transfusion adverse events and handling errors
6. Hämovigilanz, 9. Hämotherapie
17:00 – 17:05 3 Min. 2 Min.
Poster
PS-1-9
Neonatal red blood concentrates contain highly predictable extracellular K⁺ levels, which can be controlled by washing and may allow extended shelf life
3. Blutkomponenten – Herstellung und Qualitätskontrolle, 9. Hämotherapie

23/09/2022

08:30 – 10:00
Vortragssitzung
Neue Arzneimittel aus Blut
Arnold Schönberg